Welcome to our dedicated page for MAXIMUS news (Ticker: MMS), a resource for investors and traders seeking the latest updates and insights on MAXIMUS stock.
Maximus, Inc. reports developments tied to its role as a provider of tech-enabled government services for public programs. The company supports government agencies with business process management, technology solutions, health insurance eligibility and enrollment programs, clinical services, assessments, appeals and independent medical reviews across U.S. Federal Services, U.S. Services and international operations.
Recurring news includes fiscal results, guidance updates, sales-pipeline commentary, segment trends, clinical program demand and productivity initiatives. Company updates also cover AI-enabled tools such as Accuracy Assistant for state SNAP programs, quarterly cash dividends, common-stock repurchase authorizations and governance changes involving senior legal and corporate-secretary roles.
Maximus (NYSE: MMS) has secured a $100 million contract with the Centers for Disease Control and Prevention (CDC) for one base year plus four option years. The contract aims to enhance the CDC-INFO program, providing vital health information to Americans. Maximus will utilize its technology and operational expertise to improve service delivery, especially post-COVID-19. The company has previously supported the CDC-VAX program during the pandemic, earning multiple awards for its efforts.
Maximus (NYSE: MMS) announced it will release its financial results for the fiscal year and quarter ending September 30, 2022, after market close on November 21, 2022. A conference call will follow on November 22, 2022, at 9:00 a.m. ET. Shareholders can submit questions for management via email until one hour prior to the call. The event will be accessible to the public through a webcast and by phone.
Maximus (NYSE:MMS) has announced the transition of Dr. Arvenita W. Cherry to the role of President of the Maximus Foundation, effective October 1. She succeeds Dr. John Boyer, who served for 17 years and will remain as Chairman until his retirement later this fiscal year. The Maximus Foundation is dedicated to supporting community and healthcare initiatives, recently distributing $2 million in grants to 167 nonprofits in the U.S. Dr. Cherry aims to align the foundation’s focus with the company’s diversity, equity, and inclusion strategies.
Maximus (NYSE: MMS) has declared a quarterly cash dividend of $0.28 per share, set to be paid on November 30, 2022. Shareholders must be on record by November 15, 2022 to qualify for this dividend. This move highlights Maximus's commitment to returning income to its shareholders, reflecting the company's financial health and operational stability.
Maximus (NYSE: MMS) has secured a new contract valued at $6.6 billion from the Centers for Medicare & Medicaid Services (CMS) to support Contact Center Operations. This contract aims to assist 75 million Americans in accessing Medicare and health insurance through the Federal Marketplace initiated by the Affordable Care Act. The contract includes a transition period and nine optional one-year extensions, enhancing Maximus' role in delivering customer service and information about federal healthcare programs.
Maximus (NYSE: MMS) reported a revenue decline of $118 million for Q3 FY2022, totaling $1.13 billion, impacted by a $413 million reduction in COVID-19 response work. Despite this, organic growth in the U.S. Federal Services Segment and a pipeline of signed contracts totaling $4.02 billion highlight future growth potential. Diluted EPS stood at $0.51, affected by an $11.7 million write-down. Full-year guidance remains unchanged for revenue at $4.6 billion, while EPS is projected between $2.85 and $3.05. A quarterly dividend of $0.28 per share will be paid on August 31, 2022.
Maximus (NYSE: MMS) will release its financial results for the three and nine months ending June 30, 2022, on August 3, 2022, after market close. A conference call will follow on August 4 at 9:00 a.m. ET. Shareholders can submit questions to management before the call by emailing IR@maximus.com. To listen, participants can join via webcast or phone: 877.407.8289 (Domestic) / +1.201.689.8341 (International). A recording will be available post-call.
Maximus (NYSE: MMS) has announced a quarterly cash dividend of $0.28 per share, set to be paid on August 31, 2022. Shareholders of record as of August 15, 2022, will receive this dividend. The company continues to focus on improving public service delivery through innovative solutions, reinforcing its role as a strategic partner to governments globally.
Maximus (NYSE: MMS) announced over $2 million in grants to 167 nonprofit organizations in the United States for 2022, marking a record high in the Maximus Foundation's history. This is an increase from $1.2 million awarded to 154 organizations in 2021. Funding priorities include community development, youth programs, and healthcare services. Nearly $400,000 is allocated to 34 nonprofits focused on homelessness, and over $300,000 to organizations combating child abuse and hunger. The grants aim to promote self-sufficiency and improve community well-being.
Maximus (NYSE: MMS) held its Investor Day on May 24 at 9:00 a.m. ET. Presentations were made by President Bruce Caswell, CFO David Mutryn, and three Segment General Managers. They discussed the company's growth strategy, focusing on expectations for organic growth and profit margins. The live webcast and related materials were available on the Maximus Investor Relations website, with a replay accessible afterward. Maximus, a global leader in government services, aims to enhance public service delivery through innovative business processes and technology solutions.